| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003414A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 02/08/1996 | WO1996003152A1 Antisense oligonucleotides against hepatitis b viral replication |
| 02/08/1996 | WO1996003133A1 Novel anti-hiv drug |
| 02/08/1996 | WO1995033851A3 Method for the detection of the antibiotic resistance spectrum of mycobacterium species |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | CA2196070A1 Antisense oligonucleotides against hepatitis b viral replication |
| 02/08/1996 | CA2195321A1 Soluble combinatorial libraries |
| 02/08/1996 | CA2195099A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | CA2195089A1 Combinatorial libraries of molecules and methods for producing same |
| 02/07/1996 | EP0695941A2 Method and apparatus for packaging a chip |
| 02/07/1996 | EP0695549A1 Use of polydeoxyribonucleotides in diabetic neuropathies |
| 02/07/1996 | EP0695367A1 Ligase chain reaction with endonuclease iv correction and contamination control |
| 02/07/1996 | EP0695347A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 02/07/1996 | EP0695311A1 Cellulose binding domain |
| 02/07/1996 | EP0695306A1 Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
| 02/07/1996 | EP0695305A1 Method of forming oligonucleotides |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 02/07/1996 | EP0695170A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles |
| 02/06/1996 | US5489743 Transgenic animal models for thrombocytopenia |
| 02/06/1996 | US5489678 Photolabile nucleoside and peptide protecting groups |
| 02/06/1996 | US5489677 Nuclease resistant oligonucleotide analogs |
| 02/06/1996 | US5489527 Translation of m-RNA |
| 02/06/1996 | CA2155451A1 Dna sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 02/06/1996 | CA2057456C Anti depression pharmaceutical |
| 02/02/1996 | EP0702675A4 Method for palladium catalyzed carbon-carbon coupling and products |
| 02/01/1996 | WO1996002669A1 Conjugates of metal complexes and oligonucleotides, which specifically bond to specific target structures, agents containing these conjugates, their use in nmr diagnosis as well as process for their production |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002574A1 Process for modifying the stability of antibodies |
| 02/01/1996 | WO1996002560A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002557A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/01/1996 | WO1996002556A2 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002554A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | WO1996002552A1 Lung cancer marker |
| 02/01/1996 | WO1996002500A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 02/01/1996 | WO1996002274A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | WO1995013385A3 Thrombin mutants |
| 02/01/1996 | DE4427821A1 Stabilised super-paramagnetic aggregate particles |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195403A1 Lung cancer marker |
| 02/01/1996 | CA2195397A1 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195091A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | CA2194561A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 02/01/1996 | CA2194558A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | CA2194398A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 01/31/1996 | EP0694559A2 2',5'-Phosphorothioate oligoadenylates and antiviral uses thereof |
| 01/31/1996 | EP0694079A1 Enzymatic ligation of 3'-amino-substituted olignucleotides |
| 01/31/1996 | EP0694075A1 Thermostable dna topoisomerase v |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0693940A1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells |
| 01/31/1996 | EP0693936A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 01/31/1996 | EP0693874A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 01/31/1996 | EP0514513B1 Method and means for oligonucleotide synthesis |
| 01/30/1996 | US5488099 Multifunctional chimeric neurotrophic factors |
| 01/30/1996 | US5487984 Processes for producing tumor necrosis factor |
| 01/30/1996 | US5487983 Expression systems for making single-chain monellin analogs |
| 01/30/1996 | US5487972 Nucleic acid detection by the 5'-3'exonuclease activity of polymerases acting on adjacently hybridized oligonucleotides |
| 01/25/1996 | WO1996001895A1 Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001836A1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001617A1 Nucleic acid filters |
| 01/25/1996 | WO1996001557A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194451A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | CA2171470A1 Dna encoding phosphoenolpyruvate caboxykinase, recombinant vector and transformed plant containing the same |
| 01/24/1996 | EP0693554A1 Crucifer aft proteins and uses thereof |
| 01/24/1996 | EP0693551A1 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/24/1996 | EP0693287A1 RNA cleaving or binding oligonucleotides |
| 01/24/1996 | EP0693130A1 Targeted delivery of genes encoding antisense polyribonucleotides |
| 01/24/1996 | EP0693123A1 Modified oligonucleotides having improved anti-influenza activity |
| 01/24/1996 | EP0693078A1 Dna polymerases with enhanced thermostability and enhanced length and efficiency of primer extension |
| 01/24/1996 | EP0693065A1 Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0692930A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 01/24/1996 | EP0669897A4 Separation of nucleic acid fragments. |
| 01/24/1996 | CN1115320A Nucleosides and oligonucleotides having 2'-ether groups |
| 01/23/1996 | US5486603 Oligonucleotide having enhanced binding affinity |
| 01/23/1996 | US5486602 Genes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
| 01/22/1996 | EP0724447A4 Derivatized oligonucleotides having improved uptake and other properties |
| 01/19/1996 | CA2154030A1 Gd-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/18/1996 | WO1996001430A2 Screening for nuc inhibitors |
| 01/18/1996 | WO1996001271A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | WO1996001270A1 Human elastase iv |
| 01/18/1996 | WO1996001268A1 Purification of oligodeoxynucleotide phosphorothioates using deae 5pw anion ion-exchange chromatography and hydrophobic interaction chromatography |
| 01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
| 01/18/1996 | DE4425781A1 Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel Technetium-sulfonamide complexes, their use, pharmaceutical compositions containing them, and processes for producing the complexes and agents |
| 01/18/1996 | DE4425115A1 Verfahren zur Modifizierung der Stabilität von Antikörpern A method for modifying the stability of antibodies |
| 01/18/1996 | DE4424923A1 Conjugates of nuclease-resistant oligo:nucleotide and metal complexing agent |
| 01/18/1996 | DE4424922A1 Nuclease-resistant oligo:nucleotide conjugates |
| 01/18/1996 | DE4424577A1 Transporter protein for cationic xenobiotic(s) and pharmaceuticals, and related DNA and transformed cells |
| 01/18/1996 | CA2194396A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | CA2194391A1 Human elastase iv |
| 01/18/1996 | CA2194350A1 Purification of oligodeoxynucleotide phosphorothioates using deae 5pw anion ion-exchange chromatography and hydrophobic interaction chromatography |
| 01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
| 01/18/1996 | CA2193685A1 Screening for nuc inhibitors |